Ardelyx appoints Merdad Parsey to Board of Directors, effective April 28, 2025

ARDELYX, INC.

Merdad Parsey, M.D., Ph.D., appointed as Class I director, effective April 28, 2025.
Also appointed to Nominating and Corporate Governance Committee effective June 18, 2025.
Initial equity compensation: option and RSUs each valued at ~$225,000, plus annual cash retainers of $50k (board) and $5k (committee).
Dr. Parsey is independent per Nasdaq Listing Rule 5605.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Merdad Parsey

Director

ARDX · ARDELYX, INC.

Effective: 2025-04-28
Filed: April 29, 2025, 7:59 PM ET

On April 28, 2025, the Company appointed Merdad Parsey, M.D., Ph.D, as a member of the Board of Directors (the “Board”) of Ardelyx, Inc., a Delaware corporation (the “Company”), effective immediately

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Merdad Parsey was appointed as Director at ARDELYX, INC..

Action: appointed
Role: Director

Exact text from the filing

On April 28, 2025, the Company appointed Merdad Parsey, M.D., Ph.D, as a member of the Board of Directors (the “Board”) of Ardelyx, Inc., a Delaware corporation (the “Company”), effective immediately

View on SEC.gov

ARDELYX, INC. filing history →

Source: SEC EDGAR

accession 0001628280-25-020477

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.